Funding Clinical Trials

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areassort descending Investigator Organization Phase Trial Status Targeted Enrollment Detail
  • Alpha Thalassemia Major
Tippi MacKenzie University of California, San Francisco Phase 1 Recruiting 10
  • Beta Thalassemia
Bettina Cockroft Sangamo BioSciences, Inc. Phase 1/2 Active, not recruiting 6
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Recruiting 60
  • Leukocyte Adhesion Deficiency
Kinnari Patel Rocket Pharmaceuticals, Inc. Phase 1/2 Recruiting 9
Donald Kohn University of California, Los Angeles Phase 2 Completed 10
  • Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
Morton Cowan University of California, San Francisco Phase 1 Recruiting 15
Stephen Gottschalk St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
Judith Shizuru Stanford University Phase 1/2 Recruiting 34
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
Joseph Rosenthal City of Hope, Beckman Research Institute Phase 1 Recruiting 6
Pierre Caudrelier ExCellThera Inc. Phase 1 Launching N/A
David Williams Boston Children's Hospital Phase 2 Launching N/A
  • X-linked Chronic Granulomatous Disease
Donald Kohn University of California, Los Angeles Phase 1/2 Active, not recruiting 10
Icon for XLSX export